Jazz Pharmaceuticals

Everything we do at Jazz Pharmaceuticals is focused on three things: putting patients first, being a great place to work, and living our shared values. Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families.

We're dedicated to developing life-changing medicines for people with limited or no options, so they can live their lives more fully. Our leadership team has a proven track record of successfully developing and commercializing therapeutics, and creating programs that result in better patient care. They've also driven shareholder value, and built Jazz Pharmaceuticals into an employer of choice.

Our Board of Directors provides the leadership and guidance necessary to execute our purpose. Professor, University of California, San Francisco and Director, Teladoc Health, Inc. and Phreesia, Inc. Lead Independent Director, Jazz Pharmaceuticals plc; Chairman and Chief Executive Officer, Theravance Biopharma, Inc.

Jazz has a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in key therapeutic areas. Our focus is in neuroscience, including sleep medicine and movement disorders, and in oncology, including hematologic malignancies and solid tumors. We actively explore new options for patients including novel compounds, small molecule advancements, biologics and innovative delivery technologies.

Jazz is committed to excellence in partnering - which for us means leveraging our culture, our core values and our expertise when working with alliance partners. Together, we advance promising products and create value for both Jazz and our partners that exceeds what either of us may be able to do individually.